Pamoic acid

Pamoic acid[1][2]
Names
IUPAC name
4-[(3-Carboxy-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic acid
Other names
Embonic acid
Identifiers
901319
130-85-8 Yes
ChEBI CHEBI:50186
ChEMBL ChEMBL177880 Yes
ChemSpider 8228 Yes
EC number 204-998-0
Jmol-3D images Image
Image
MeSH Pamoic+acid
PubChem 8546
RTECS number QL2180000
UNII 7RRQ8QZ38N Yes
Properties
Molecular formula
C23H16O6
Molar mass 388.37 g·mol−1
Melting point ≥300 °C
log P 6.169
Acidity (pKa) 2.675
Hazards
Main hazards Causes skin irritation

Causes serious eye irritation
May cause respiratory irritation

EU classification Xi
R-phrases R36/37/38
S-phrases S26 S36
Except where noted otherwise, data is given for materials in their standard state (at 25 °C (77 °F), 100 kPa)
Infobox references

Pamoic acid, also called embonic acid, is a naphthoic acid derivative. Salts and esters of pamoic acid are known as pamoates or embonates. It can be prepared by the reaction of 2-hydroxy-3-naphthoic acid with formaldehyde. In pharmacology, the salt form of pamoic acid (pamoate ion) can be used as a counter ion of a drug compound to increase the solubility of the drug in water.[3] The presence of multiple oxygen atoms enables significant hydrogen bonding to occur. Hydrogen bonds facilitate the dissolution of compounds in water.

It was demonstrated that pamoic acid has agonist activity for the orphan G protein-coupled receptor GPR35 by which it activates ERK and beta-arrestin2, and causes antinociceptive activity. Although (like other drug salts) it has been considered an inactive compound by the FDA, these recent data suggest that its use may be reexamined.

References

  1. Merck Index, 12th Edition, 7136.
  2. Zhao, P.; Sharir, H.; Kapur, A.; Cowan, A.; Geller, E. B.; Adler, M. W.; Seltzman, H. H.; Reggio, P. H. et al. (2010). "Targeting of the Orphan Receptor GPR35 by Pamoic Acid: A Potent Activator of Extracellular Signal-Regulated Kinase and -Arrestin2 with Antinociceptive Activity". Molecular Pharmacology 78 (4): 560–8. doi:10.1124/mol.110.066746. PMC 2981393. PMID 20826425.
  3. Saesmaa, T; Tötterman, AM (1990). "Dissolution studies on ampicillin embonate and amoxycillin embonate". Journal of pharmaceutical and biomedical analysis 8 (1): 61–5. doi:10.1016/0731-7085(90)80007-c. PMID 2102266.

External links